PWP
VRTX icon

Private Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Private Wealth Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$930K Buy
1,873
+488
+35% +$216K 0.07% 107
2026
Q1 		$618K Buy
1,385
+150
+12% +$69.9K 0.05% 119
2025
Q4 		$560K Hold
1,235
– – 0.04% 123
2025
Q3 		$484K Sell
1,235
-250
-17% -$104K 0.03% 128
2025
Q2 		$661K Hold
1,485
– – 0.05% 115
2025
Q1 		$720K Sell
1,485
-10
-0.7% -$4.66K 0.06% 103
2024
Q4 		$602K Sell
1,495
-930
-38% -$431K 0.05% 119
2024
Q3 		$1.13M Buy
2,425
+925
+62% +$444K 0.09% 87
2024
Q2 		$703K Hold
1,500
– – 0.05% 100
2024
Q1 		$627K Sell
1,500
-1,890
-56% -$799K 0.05% 97
2023
Q4 		$1.38M Hold
3,390
– – 0.12% 74
2023
Q3 		$1.18M Sell
3,390
-50
-1% -$17.5K 0.11% 70
2023
Q2 		$1.21M Sell
3,440
-90
-3% -$30.3K 0.11% 69
2023
Q1 		$1.11M Buy
+3,530
New +$1.06M 0.11% 75
2021
Q3 		– Sell
-14,355
Closed -$2.89M – 84
2021
Q2 		$2.89M Sell
14,355
-458
-3% -$95.8K 0.27% 51
2021
Q1 		$3.18M Buy
14,813
+934
+7% +$205K 0.34% 47
2020
Q4 		$3.28M Buy
13,879
+2,459
+22% +$564K 0.36% 47
2020
Q3 		$3.11M Buy
11,420
+776
+7% +$214K 0.36% 43
2020
Q2 		$3.09M Buy
10,644
+405
+4% +$110K 0.42% 46
2020
Q1 		$2.44M Buy
+10,239
New +$2.35M 0.41% 44
2014
Q4 		– Sell
-2,000
Closed -$225K – 172
2014
Q3 		$225K Buy
+2,000
New +$190K 0.05% 154

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Private Wealth Partners's VRTX Position: Q2 2026 in Review

Private Wealth Partners increased its Vertex Pharmaceuticals (VRTX) stake by 35% in Q2 2026, buying an estimated $216K and bringing the position to 1,873 shares worth $930K. The position accounts for 0.07% of the portfolio, ranked #107.

Private Wealth Partners first reported a position in VRTX in Q3 2014 and has held it in 21 quarters since. The position peaked at $3.28M in Q4 2020. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Private Wealth Partners held 1,873 shares of Vertex Pharmaceuticals worth $930K as of Q2 2026.
  • Private Wealth Partners bought 488 Vertex Pharmaceuticals shares in Q2 2026, an estimated $216K.
  • Vertex Pharmaceuticals made up 0.07% of Private Wealth Partners's portfolio in Q2 2026, its #107 holding.
  • Private Wealth Partners first reported a position in Vertex Pharmaceuticals in Q3 2014 and has held it in 21 quarters since.
  • Private Wealth Partners's Vertex Pharmaceuticals position peaked at $3.28M in Q4 2020.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Private Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.